These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 10610156)

  • 1. Numbers needed to treat derived from meta-analysis. Length of follow up is poorly reported.
    D'Amico R; Deeks JJ; Altman DG
    BMJ; 1999 Oct; 319(7218):1200. PubMed ID: 10610156
    [No Abstract]   [Full Text] [Related]  

  • 2. Numbers needed to treat derived from meta-analysis. Using patient years may also be misleading.
    Hopayian K; McGough J
    BMJ; 1999 Oct; 319(7218):1199-200. PubMed ID: 10610154
    [No Abstract]   [Full Text] [Related]  

  • 3. Numbers needed to treat derived from meta analysis. NNT is a tool, to be used appropriately.
    Moore A; McQuay H
    BMJ; 1999 Oct; 319(7218):1200. PubMed ID: 10610155
    [No Abstract]   [Full Text] [Related]  

  • 4. [Numbers needed for treatment and their respective confidence intervals: useful tools to assess clinical significance and uncertainty associated with medical interventions].
    Sampaio C; Ferreira J; Costa J
    Rev Port Cardiol; 2000 Dec; 19(12):1303-8. PubMed ID: 11220124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Numbers needed to treat derived from meta-analysis. Are an absurdity.
    Charlton BG
    BMJ; 1999 Oct; 319(7218):1199. PubMed ID: 10541527
    [No Abstract]   [Full Text] [Related]  

  • 6. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Piscione F; Piccolo R; Cassese S; Galasso G; Chiariello M
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):323-32. PubMed ID: 19360858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Numbers needed to treat derived from meta-analysis: a word of caution.
    Marx A; Bucher HC
    ACP J Club; 2003; 138(2):A11-2. PubMed ID: 12614141
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone therapy and radiotherapy for early prostate cancer: a utility-adjusted number needed to treat (NNT) analysis.
    Jani AB; Kao J; Heimann R; Hellman S
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):687-94. PubMed ID: 15708246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exaggeration of treatment benefits using the "event-based" number needed to treat.
    Aaron SD; Fergusson DA
    CMAJ; 2008 Sep; 179(7):669-71. PubMed ID: 18809898
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of open vs. laparoscopic abdominal rectopexy for full-thickness rectal prolapse: a meta-analysis.
    Purkayastha S; Tekkis P; Athanasiou T; Aziz O; Paraskevas P; Ziprin P; Darzi A
    Dis Colon Rectum; 2005 Oct; 48(10):1930-40. PubMed ID: 15981060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Number needed to treat (NNT)-- misleading, misunderstood, misused?].
    Wisløff T; Halvorsen PA; Kristiansen IS
    Tidsskr Nor Laegeforen; 2004 Aug; 124(15):1926-9. PubMed ID: 15306861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willy Sutton and the number needed to treat.
    Browner WS
    Am J Med; 2004 Apr; 116(8):564-5. PubMed ID: 15063821
    [No Abstract]   [Full Text] [Related]  

  • 15. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.
    Sweeting MJ; Sutton AJ; Lambert PC
    Stat Med; 2004 May; 23(9):1351-75. PubMed ID: 15116347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials.
    Hutton JL
    Br J Haematol; 2009 Jun; 146(1):27-30. PubMed ID: 19438480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive devices in primary or rescue PCI: a meta-analysis of randomized trials.
    Burzotta F; Testa L; Giannico F; Biondi-Zoccai GG; Trani C; Romagnoli E; Mazzari M; Mongiardo R; Siviglia M; Niccoli G; De Vita M; Porto I; Schiavoni G; Crea F
    Int J Cardiol; 2008 Jan; 123(3):313-21. PubMed ID: 17383756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of repeated measures study designs.
    Peters JL; Mengersen KL
    J Eval Clin Pract; 2008 Oct; 14(5):941-50. PubMed ID: 19018929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
    Moodie PF; Nelson NA; Koch GG
    Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.